MRTX

Mirati Therapeutics, Inc. Common Stock
MRTX

Overview Fund Activity
Delisted

MRTX was delisted on the 22nd of January, 2024.

Back to rankings

233 hedge funds and large institutions have $2.95B invested in Mirati Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 99 increasing their positions, 72 reducing their positions, and 47 closing their positions.

Holders
233
Holders Change
-10
Holders Change %
-4.12%
% of All Funds
3.76%
Holding in Top 10
10
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-33.33%
% of All Funds
0.16%
New
43
Increased
99
Reduced
72
Closed
47
Calls
$86.2M
Puts
$34.1M
Net Calls
+$52.2M
Net Calls Change
+$69.3M

Top Buyers

1
RI
1
RTW Investments
New York
$165M
2
AC
2
Armistice Capital
New York
$158M
3
State Street
3
State Street
Massachusetts
$115M
4
Morgan Stanley
4
Morgan Stanley
New York
$76.6M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$34.1M

Top Sellers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$0
2
EC
2
EcoR1 Capital
California
$0
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$31.1M
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$23.9M
5
Ameriprise
5
Ameriprise
Minnesota
$28.9M
Name Market Value Shares Shares
Change 		Shares
Change %
ACA
1
Avoro Capital Advisors
New York
$252M 5,555,555 +5,000 +0.1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$225M 4,973,888 +245,589 +5%
RI
3
RTW Investments
New York
$165M 3,643,114 +1,760,451 +94%
AC
4
Armistice Capital
New York
$158M 3,488,000 +1,588,000 +84%
AH
5
Aviva Holdings
Bahamas
$142M 3,135,966 – –
Wellington Management Group
6
Wellington Management Group
Massachusetts
$137M 3,016,335 -452,976 -13%
BlackRock
7
BlackRock
New York
$121M 2,662,922 +235,171 +10%
State Street
8
State Street
Massachusetts
$115M 2,545,576 +974,037 +62%
PA
9
Perceptive Advisors
New York
$99.3M 2,191,425 -593,371 -21%
BC
10
Boxer Capital
California
$90.6M 2,000,000 – –
AG
11
Artal Group
Luxembourg
$83M 1,832,758 +507,758 +38%
Morgan Stanley
12
Morgan Stanley
New York
$76.6M 1,689,711 +702,556 +71%
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$64.2M 1,416,728 +273,973 +24%
BBA
14
Baker Bros. Advisors
New York
$63.9M 1,409,784 – –
CCM
15
Camber Capital Management
Massachusetts
$63.4M 1,400,000 -600,000 -30%
O
16
OrbiMed
New York
$58.2M 1,283,692 -135,200 -10%
PBA
17
Paradigm Biocapital Advisors
New York
$57.5M 1,267,970 +417,585 +49%
RSCM
18
Rock Springs Capital Management
Maryland
$36.5M 805,024 -61,752 -7%
CS
19
Candriam SCA
Luxembourg
$34.8M 767,596 +105,095 +16%
Point72 Asset Management
20
Point72 Asset Management
Connecticut
$34.1M 753,600 +651,753 +640%
OCA
21
Octagon Capital Advisors
New York
$34M 750,000 +529,000 +239%
Franklin Resources
22
Franklin Resources
California
$33.4M 736,768 -723,425 -50%
Geode Capital Management
23
Geode Capital Management
Massachusetts
$32M 707,345 +51,395 +8%
Fiera Capital (Canada)
24
Fiera Capital (Canada)
Quebec, Canada
$31.4M 692,657 +159,307 +30%
Fidelity Investments
25
Fidelity Investments
Massachusetts
$31.1M 686,028 -1,454,594 -68%
1
2 3 4 5